Validation of potential therapeutic targets in alveolar soft part sarcoma: An immunohistochemical study utilizing tissue microarray

Histopathology

Volumn 55, Issue 6, 2009, Pages 750-755

  Lazar, Alexander J ^a,b   Lahat, Guy ^b   Myers, Sarah E ^b,c   Smith, Kerrington D ^b   Zou, Changye ^b   Wang, Wei Lien ^a   Lopez Terrada, Dolores ^a   Lev, Dina ^b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Department of Surgical Oncology ^*  (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Alveolar soft part sarcoma; Angiogenesis; ASPSCR1 TFE3; C Met; HGF; VEGF

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE B; PROTEIN P53; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; VASCULOTROPIN; VIMENTIN;

ALVEOLAR SOFT PART SARCOMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TISSUE MICROARRAY;

HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; SARCOMA, ALVEOLAR SOFT PART; SOFT TISSUE NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 70849112399     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03436.x     Document Type: Article

References (23)

1. Christopherson WM, Foote FW Jr., Stewart FW. Alveolar soft-part sarcomas; structurally characteristic tumors of uncertain histogenesis. Cancer 1952 5 100 111.
2. Folpe AL, Deyrup AT. Alveolar soft-part sarcoma: a review and update. J. Clin. Pathol. 2006 59 1127 1132.
3. Portera CA Jr., Ho V, Patel SR et al. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer 2001 91 585 591.
4. Ogose A, Yazawa Y, Ueda T et al. Alveolar soft part sarcoma in Japan: multi-institutional study of 57 patients from the Japanese Musculoskeletal Oncology Group. Oncology 2003 65 7 13.
5. Lieberman PH, Brennan MF, Kimmel M, Erlandson RA, Garin-Chesa P, Flehinger BY. Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer 1989 63 1 13.
6. Lahat G, Tuvin D, Wei C et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann. Surg. Oncol. 2008 15 2739 2748.
7. Vistica DT, Hollingshead M, Borgel SD et al. Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy. J. Pediatr. Hematol. Oncol. 2009 31 561 570.
8. Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009 136 823 837.
9. Weinstein IB, Joe A. Oncogene addiction. Cancer Res. 2008 68 3077 3080 discussion 3080.
10. Ladanyi M, Lui MY, Antonescu CR et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001 20 48 57.
11. Lazar AJ, Das P, Tuvin D et al. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma. Clin. Cancer Res. 2007 13 7314 7321.
12. Stockwin LH, Vistica DT, Kenney S et al. Gene expression profiling of alveolar soft-part sarcoma (ASPS). BMC Cancer 2009 9 22.
13. Ma J, Waxman DJ. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol. Cancer Ther. 2008 7 3670 3684.
14. Goh PP, Sze DM, Roufogalis BD. Molecular and cellular regulators of cancer angiogenesis. Curr. Cancer Drug Targets 2007 7 743 758.
15. Tsuda M, Davis IJ, Argani P et al. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res. 2007 67 919 929.
16. Gentile A, Trusolino L, Comoglio PM. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev. 2008 27 85 94.
17. Jun HJ, Lee J, Lim DH et al. Expression of MET in alveolar soft part sarcoma. Med. Oncol. 2009 Epub ahead of print).
18. Banihani MN, Al Manasra AR. Spontaneous regression in alveolar soft part sarcoma: case report and literature review. World J. Surg. Oncol. 2009 7 53.
19. Taubert H, Meye A, Wurl P. Soft tissue sarcomas and p53 mutations. Mol. Med. 1998 4 365 372.
20. Lahat G, Lazar A, Lev D. Sarcoma epidemiology and etiology: potential environmental and genetic factors. Surg. Clin. North Am. 2008 88 451 481.
21. Das P, Kotilingam D, Korchin B et al. High prevalence of p53 exon 4 mutations in soft tissue sarcoma. Cancer 2007 109 2323 2333.
22. Auerbach HE, Brooks JJ. Alveolar soft part sarcoma. A clinicopathologic and immunohistochemical study. Cancer 1987 60 66 73.
23. Lazar A, Abruzzo LV, Pollock RE, Lee S, Czerniak B. Molecular diagnosis of sarcomas: chromosomal translocations in sarcomas. Arch. Pathol. Lab. Med. 2006 130 1199 1207.